A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression

NCT01774045 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: PDC-1421
DRUG: Placebo

Sponsor

BioLite, Inc.